Female CPF-treated TgF344-AD rats had significantly greater Iba1+ staining relative to vehicle-treated female TgF344-AD rats, while male CPF-treated TgF344-AD exhibited a trending population shift in Iba1+ cells relative to vehicle-treated male TgF344-AD rats. The gene discussed is NR5A2; the disease is Alzheimer disease.